ClinicalTrials.gg
CompletedNCT04371783FETUpdated Nov 9, 2026

A Randomized Trial Comparing the Live Birth Rate of Immediate Versus Delayed FET Following a Freeze-all Strategy

An interventional study of Immediate FET and Delayed FET in IVF and Frozen Embryo Transfer, sponsored by ShangHai Ji Ai Genetics & IVF Institute. Completed at 1 site in China. Open to female participants aged 20 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by ShangHai Ji Ai Genetics & IVF Institute · Not applicable, Interventional, and Treatment

How we know

Updated Nov 9, 2026Now CompletedEnrollment updatedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
828
Allocation
Randomized
Ages
20 Years to 40 Years
Sex
Female
01

Study summary

This randomized trial we aim to compare the live birth rate of immediate versus delayed FET replacing a single blastocyst in the first FET of the first stimulated IVF cycle following. The hypothesis is that the live birth rate of the immediate FET is higher than the delayed FET replacing a single blastocyst in the first FET of the first stimulated IVF cycle following a freeze-all strategy. Women will undergo IVF/ICSI in the centre as clinically indicated. Standard ovarian stimulation with gonadotrophins in a Gonadotrophin releasing hormone (GnRH) antagonist protocol will be employed. Hormone replacement treatment (HRT) will be used in subsequent FET cycles. On Day 3 of the menstrual cycle, we will measure the anxiety levels using the Chinese State-Trait Anxiety Inventory and serum E2, cortisol levels will be checked on the same day.

Recruited women having the first FET cycle following a freeze all strategy will be randomly assigned on the day of blastocyst(s) freezing according to a computer-generated randomization list into one of the following two groups.

02

Conditions studied

  • IVF
  • Frozen Embryo Transfer
03

In context

Lead sponsor

ShangHai Ji Ai Genetics & IVF Institute is the lead sponsor of 26 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Women aged 20-40 years at the time of IVF/ICSI
  2. Women undergoing their first FET of the first IVF cycle following a freeze-all strategy
  3. Undergoing IVF with GnRH antagonist
  4. At least one frozen blastocyst

Exclusion criteria

Exclusion Criteria:

  1. Severe ovarian hyperstimulation syndrome during the first IVF/ICSI cycle
  2. Preimplantation genetic testing
  3. Use of donor oocytes
  4. Presence of untreated hydrosalpinx or endometrial polyp on scanning during ovarian stimulation
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
828 participants (actual)

Study arms

  • Other
    Immediate FET group

    FET will be performed in the first menstrual cycle following the stimulated IVF cycle

    Procedure: Immediate FET

  • Other
    Delayed FET group

    FET will be performed in the second menstrual cycle following the stimulated IVF cycle

    Procedure: Delayed FET

Interventions

  • ProcedureImmediate FET

    FET is performed in the first menstrual cycle following the stimulated IVF cycle

  • ProcedureDelayed FET

    FET is performed in the second menstrual cycle following the stimulated IVF cycle

06

What researchers measure

Primary outcomes

  1. live birth

    deliveries ≥22 weeks gestation with heartbeat and breath

    Time frame: 1 year after FET

Secondary outcomes

  1. positive hCG

    serum β-hCG ≥10 mIU/mL

    Time frame: 2 weeks after FET

  2. clinical pregnancy

    presence of intrauterine gestational sac by trans-vaginal ultrasound at 6 gestational weeks.

    Time frame: 6 weeks' gestation

  3. ongoing pregnancy

    a viable pregnancy beyond 12 weeks' gestation

    Time frame: 12 weeks' gestation

  4. implantation rate

    the number of gestational sacs per blastocyst transferred

    Time frame: 6 weeks' gestation

  5. miscarriage

    a clinically recognized pregnancy loss before the 22 weeks of pregnancy

    Time frame: 1 year after FET

  6. multiple pregnancy

    more than one intrauterine sacs on scanning

    Time frame: multiple pregnancy beyond gestation 12 weeks

  7. ectopic pregnancy

    pregnancy outside the uterine cavity

    Time frame: ectopic pregnancy during 12 weeks gestation

  8. birthweight of newborns

    the birth weight of newborns

    Time frame: 1 year after FET

07

Study locations

1 site
08

References and documents

Publications

  • Doody KJ. Cryopreservation and delayed embryo transfer-assisted reproductive technology registry and reporting implications. Fertil Steril. 2014 Jul;102(1):27-31. doi: 10.1016/j.fertnstert.2014.04.048. Epub 2014 Jun 4. PubMed 24907917 ↗
  • Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Hudson C, Thomas S. Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfer in normal responders. Fertil Steril. 2011 Aug;96(2):344-8. doi: 10.1016/j.fertnstert.2011.05.050. Epub 2011 Jul 6. PubMed 21737072 ↗
  • Venetis CA, Kolibianakis EM, Bosdou JK, Lainas GT, Sfontouris IA, Tarlatzis BC, Lainas TG. Estimating the net effect of progesterone elevation on the day of hCG on live birth rates after IVF: a cohort analysis of 3296 IVF cycles. Hum Reprod. 2015 Mar;30(3):684-91. doi: 10.1093/humrep/deu362. Epub 2015 Jan 12. PubMed 25586787 ↗
  • Santos-Ribeiro S, Polyzos NP, Lan VT, Siffain J, Mackens S, Van Landuyt L, Tournaye H, Blockeel C. The effect of an immediate frozen embryo transfer following a freeze-all protocol: a retrospective analysis from two centres. Hum Reprod. 2016 Nov;31(11):2541-2548. doi: 10.1093/humrep/dew194. Epub 2016 Sep 8. PubMed 27609984 ↗
  • Santos-Ribeiro S, Siffain J, Polyzos NP, van de Vijver A, van Landuyt L, Stoop D, Tournaye H, Blockeel C. To delay or not to delay a frozen embryo transfer after a failed fresh embryo transfer attempt? Fertil Steril. 2016 May;105(5):1202-1207.e1. doi: 10.1016/j.fertnstert.2015.12.140. Epub 2016 Jan 21. PubMed 26806686 ↗
  • Lattes K, Checa MA, Vassena R, Brassesco M, Vernaeve V. There is no evidence that the time from egg retrieval to embryo transfer affects live birth rates in a freeze-all strategy. Hum Reprod. 2017 Feb;32(2):368-374. doi: 10.1093/humrep/dew306. Epub 2016 Dec 16. PubMed 27986819 ↗
  • Volodarsky-Perel A, Eldar-Geva T, Holzer HE, Schonberger O, Reichman O, Gal M. Cryopreserved embryo transfer: adjacent or non-adjacent to failed fresh long GnRH-agonist protocol IVF cycle. Reprod Biomed Online. 2017 Mar;34(3):267-273. doi: 10.1016/j.rbmo.2016.11.013. Epub 2016 Dec 16. PubMed 28041829 ↗
  • Higgins C, Healey M, Jatkar S, Vollenhoven B. Interval between IVF stimulation cycle and frozen embryo transfer: Is there a benefit to a delay between cycles? Aust N Z J Obstet Gynaecol. 2018 Apr;58(2):217-221. doi: 10.1111/ajo.12696. Epub 2017 Sep 14. PubMed 28905357 ↗
  • Li H, Zhang W, Chen J, Lu X, Li L, Sun X, Ng EH. Immediate versus delayed single blastocyst transfer following the first stimulated IVF cycle in the freeze-all strategy: a study protocol for a randomised controlled trial. BMJ Open. 2024 May 8;14(5):e081018. doi: 10.1136/bmjopen-2023-081018. PubMed 38719320 ↗

Individual participant data

Plan to share: Yes — Individual participant data that underlie the results after deidentification (text, tables, figures, and appendices) and study protocol will be shared.

Supporting information: Study protocol, Statistical analysis plan, Clinical study report, Analytic code

Time frame: Data will be available when beginning 3 months and ending 5 years following article publication.

Access criteria: To achieve aims in the approved proposal, researchers who provide a methodologically sound proposal will be shared with. Proposals should be directed to lihe198900@163.com.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from May 2020 to primary completion in Jun 2026, 72 months.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 29, 2020
First posted
May 1, 2020
StartActual
May 4, 2020
Primary completionActual
Jun 1, 2026
CompletionActual
Jun 30, 2026
Last update
Nov 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Completed
changed Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    Active, not recruiting→Completed
    + 2 other changes: verification date and date precision

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT04371783
Lead sponsor
ShangHai Ji Ai Genetics & IVF Institute
Responsible party
Sponsor
First posted
May 1, 2020
Start date
May 4, 2020
Primary completion
Jun 1, 2026
Completion
Jun 30, 2026
Last update
Nov 9, 2026

Study contacts

Xiaoxi Sun, Phd
study director · Shanghai JiAi Genetics & IVF Institute

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion